Invention Publication
- Patent Title: MK2 INHIBITORS AND USES THEREOF
-
Application No.: US18495004Application Date: 2023-10-26
-
Publication No.: US20240190890A1Publication Date: 2024-06-13
- Inventor: Xirui Hu , Lixin Qiao , Boris Seletsky , Matthew Patton , Min Cao , Farid van der Mei , Guobin Miao , Ivar McDonald , Carolyn Dzierba
- Applicant: Bristol-Myers Squibb Company , Celgene Corporation
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company,Celgene Corporation
- Current Assignee: Bristol-Myers Squibb Company,Celgene Corporation
- Current Assignee Address: US NJ Princeton
- Main IPC: C07D495/14
- IPC: C07D495/14
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the MK2 inhibitors of the Formula:
Information query
